Daniel Grosslight
Stock Analyst at Citigroup
(1.11)
# 3,835
Out of 5,117 analysts
112
Total ratings
33.82%
Success rate
-15.4%
Average return
Main Sectors:
Stocks Rated by Daniel Grosslight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHR Phreesia | Maintains: Buy | $34 → $29 | $17.02 | +70.39% | 7 | Dec 9, 2025 | |
| EVH Evolent Health | Maintains: Buy | $12 → $9.5 | $4.12 | +130.58% | 5 | Nov 21, 2025 | |
| HCAT Health Catalyst | Maintains: Neutral | $3.5 → $3.25 | $2.42 | +34.30% | 11 | Nov 11, 2025 | |
| CTEV Claritev | Maintains: Buy | $74 → $80 | $42.03 | +90.34% | 3 | Nov 10, 2025 | |
| CAH Cardinal Health | Maintains: Neutral | $165 → $190 | $208.29 | -8.78% | 10 | Oct 31, 2025 | |
| WAY Waystar Holding | Maintains: Buy | $47 → $49 | $32.98 | +48.57% | 2 | Oct 31, 2025 | |
| TDOC Teladoc Health | Maintains: Neutral | $9.5 → $11 | $7.12 | +47.47% | 12 | Oct 21, 2025 | |
| MCK McKesson | Maintains: Buy | $820 → $860 | $828.26 | +3.83% | 8 | Sep 24, 2025 | |
| OMI Owens & Minor | Maintains: Buy | $11 → $7 | $2.77 | +152.71% | 7 | Aug 12, 2025 | |
| AGL agilon health | Downgrades: Neutral | $3 → $1 | $0.73 | +37.78% | 6 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $25 → $30 | $34.31 | -12.56% | 11 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $6.25 | $2.75 | +127.27% | 7 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $24.13 | +3.61% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $10 | $4.12 | +142.72% | 7 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $7 → $8 | $12.69 | -36.96% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1.25 | $1.37 | -8.76% | 5 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7 → $3.5 | $3.64 | -3.85% | 2 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $10.25 | +26.83% | 1 | Dec 11, 2019 |
Phreesia
Dec 9, 2025
Maintains: Buy
Price Target: $34 → $29
Current: $17.02
Upside: +70.39%
Evolent Health
Nov 21, 2025
Maintains: Buy
Price Target: $12 → $9.5
Current: $4.12
Upside: +130.58%
Health Catalyst
Nov 11, 2025
Maintains: Neutral
Price Target: $3.5 → $3.25
Current: $2.42
Upside: +34.30%
Claritev
Nov 10, 2025
Maintains: Buy
Price Target: $74 → $80
Current: $42.03
Upside: +90.34%
Cardinal Health
Oct 31, 2025
Maintains: Neutral
Price Target: $165 → $190
Current: $208.29
Upside: -8.78%
Waystar Holding
Oct 31, 2025
Maintains: Buy
Price Target: $47 → $49
Current: $32.98
Upside: +48.57%
Teladoc Health
Oct 21, 2025
Maintains: Neutral
Price Target: $9.5 → $11
Current: $7.12
Upside: +47.47%
McKesson
Sep 24, 2025
Maintains: Buy
Price Target: $820 → $860
Current: $828.26
Upside: +3.83%
Owens & Minor
Aug 12, 2025
Maintains: Buy
Price Target: $11 → $7
Current: $2.77
Upside: +152.71%
agilon health
Aug 6, 2025
Downgrades: Neutral
Price Target: $3 → $1
Current: $0.73
Upside: +37.78%
May 6, 2025
Maintains: Sell
Price Target: $25 → $30
Current: $34.31
Upside: -12.56%
Jan 10, 2025
Maintains: Buy
Price Target: $7 → $6.25
Current: $2.75
Upside: +127.27%
Apr 22, 2024
Initiates: Buy
Price Target: $25
Current: $24.13
Upside: +3.61%
Aug 9, 2023
Maintains: Neutral
Price Target: $9 → $10
Current: $4.12
Upside: +142.72%
Aug 4, 2023
Downgrades: Sell
Price Target: $7 → $8
Current: $12.69
Upside: -36.96%
Apr 28, 2023
Maintains: Neutral
Price Target: $1.5 → $1.25
Current: $1.37
Upside: -8.76%
Nov 16, 2021
Downgrades: Neutral
Price Target: $7 → $3.5
Current: $3.64
Upside: -3.85%
Dec 11, 2019
Initiates: Outperform
Price Target: $13
Current: $10.25
Upside: +26.83%